Clinical trial · Interventional
Effect of Endurance and Endurance-Strength Training on Inflammatory Markers in Women With Abdominal Obesity
NCT03444207CI-TRIAL-00031783ENDOFITcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study was to compare the effects of three months' endurance training and three months' endurance-strength training on inflammatory markers in women with abdominal obesity.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Obesity | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Endurance-strength training | Behavioral | — | UNRESOLVED |
| Endurance training | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Group A
- description
- Endurance training
- interventionNames
- Behavioral: Endurance training
- type
- EXPERIMENTAL
- label
- Group B
- description
- Endurance-strength training
- interventionNames
- Behavioral: Endurance-strength training
Primary outcomes (2)
- measure
- C-reactive protein (CRP) at baseline
- timeFrame
- At baseline
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * informed written consent; * simple obesity; * age from 18 to 65 years; * body fat content, assessed by electrical bioimpedance, equal to or more than 33%; * waist circumference more than 80 cm; * stable body weight in the one month prior to the trial. Exclusion Criteria: * secondary form of excess body mass * secondary form of arterial hypertension * mean systolic blood pressure \> 140 mmHg and/or mean diastolic blood pressure \> 90 mmHg; * diabetes; * ischemic heart disease; * stroke; * heart failure; * history of malignancy; * clinically significant heart arrhythmias; * a history of use of any dietary supplement; * serious liver or kidney damage; * abnormal thyroid gland function; * clinically significant inflammation, connective tissue disease, or arthritis; * nicotine, alcohol, or narcotic abuse; * infection; * pregnancy, childbirth, or lactation; * any other condition that would make participation not in the best interest of the subject, or could prevent the efficacy of the study.
References
Publications (1)
- DERIVEDJamka M, Piotrowska-Brudnicka SE, Karolkiewicz J, Skrypnik D, Bogdanski P, Cielecka-Piontek J, Sultanova G, Walkowiak J, Madry E. The Effect of Endurance and Endurance-Strength Training on Bone Health and Body Composition in Centrally Obese Women-A Randomised Pilot Trial. Healthcare (Basel). 2022 Apr 28;10(5):821. doi: 10.3390/healthcare10050821. PMID 35627958